| AML | Acute myeloid leukemia |
| APC | Allophycocyanin |
| BCMA | B cell maturation antigen |
| CAR | Chimeric antigen receptor |
| CD | Cluster of Differentiation |
| CH | Constant Heavy |
| eGFP | enhanced Green Fluorescent Protein |
| EMA | European Medicines Agency |
| FDA | Federal and Drug Administration |
| Flt3L | FMS-like tyrosine kinase 3 ligand |
| HBSHcAbs | HEPES-buffered salineHeavy-chain antibodies |
| HPC | Hematopoietic precursor cell |
| VHH | Variable domain of the heavy-chain of HcAbs |
| IFN-γ | Interferon gamma |
| IgG | Immunoglobulin G |
| IL-2 | Interleukin 2 |
| IRES | Internal Ribosomal Entry Site |
| NSG | Nonobese diabetic scid gamma |
| PBMC | Peripheral blood mononuclear cells |
| PBS | Phosphate buffered saline |
| PCR | Polymerase chain reaction |
| PE | Phycoerythrin |
| PerCpCy5.5 | Peridnin-chlorophyll Cy 5.5 |
| PHA | Phytohemagglutinin |
| SCF | Stem cell factor |
| scFv | Single-chain variable fragment |
| SEM | Standard error of the mean |
| TPO | Thrombopoietin |
| VH | Variable heavy |
| VL | Variable light |
| VHH | Variable heavy homodimers |